Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages

PURPOSE: Cervical cancer (CC) is the second most frequent cancer in undeveloped countries. Serum biomarkers could be useful for evaluation of the treatment response and as a complementary means to improve diagnosis. The expression of galectin-9 is altered in cancer tissue, and higher concentrations...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes-Vallejo, Tania, Conde-Rodríguez, Ileana, Serna-Villalobos, Jocelyn, Ramírez-Díaz, Ivonne, Pérez-Villalobos, Gabriela, Delgado-López, Guadalupe, Vazquez-Zamora, Víctor Javier, Gutiérrez-Quiroz, Claudia Teresita, Ávila-Jiménez, Laura, García-Carrancá, Alejandro, Martínez-Acosta, Liliana, Santos-López, Gerardo, Reyes-Leyva, Julio, Vallejo-Ruiz, Verónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556277/
https://www.ncbi.nlm.nih.gov/pubmed/36246733
http://dx.doi.org/10.2147/OTT.S378933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556277/
https://www.ncbi.nlm.nih.gov/pubmed/36246733
http://dx.doi.org/10.2147/OTT.S378933

Ejemplares similares